Study of exceptional responders with solid tumors on chemotherapy
Part of Cancer clinical trials.
This study looks at people with solid tumor cancer (like many common carcinomas) to understand who responds exceptionally well to chemotherapy. You might be eligible if you are newly diagnosed or already receiving chemotherapy and can follow the study plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed solid tumor cancer diagnosis (carcinoma) from a lab test on tissue or body fluid.
- You are not yet treated for cancer, or you are currently receiving chemotherapy.
- Your overall functioning is acceptable for the study (no major limits expected).
- If you have HIV, you must not be taking anti-HIV medicines (antiretroviral therapy).
- You cannot be pregnant or nursing.
- You must not have had an organ transplant in the past and must be able to follow the study plan without a condition that could interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers access to experimental or non-standard cancer treatments for people with advanced solid tumors who have run out of standard options. The goal is to find new ways to treat cancers that are hard to manage.
This trial studies why some solid cancers stop responding to immune-based drugs (like anti–PD-1/PD-L1) and what can be done next. You may be eligible if your cancer has progressed after immunotherapy and you can safely undergo a tumor needle biopsy.
This Phase 1/2 study tests two investigational medicines (PE0116 and PE0105) in people with advanced solid cancers that have spread or cannot be removed by surgery. It may help shrink tumors or slow disease when standard treatments have not worked or are not tolerated.
This trial tests a combination of two new drugs (QLS31905 and/or QL1706) with chemotherapy for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if this combination can shrink tumors and help people live longer.
This study collects and analyzes tumor samples from people with advanced solid cancers to understand why some treatments work better than others and why resistance can develop. It aims to improve future treatments for patients like you.
This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.
Hear when a new Solid Tumor Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.